chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm is hard, red, warm and itching at injection site,; headache; arm is hard, red, warm and itching at injection site,; arm is hard, red, warm and itching at injection site,; arm is hard, red, warm and itching at injection site,; arm is in pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is in pain), ERYTHEMA (arm is hard, red, warm and itching at injection site,), HEADACHE (headache), VACCINATION SITE WARMTH (arm is hard, red, warm and itching at injection site,) and INJECTION SITE PRURITUS (arm is hard, red, warm and itching at injection site,) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is in pain). On 30-Mar-2021, the patient experienced ERYTHEMA (arm is hard, red, warm and itching at injection site,), HEADACHE (headache), VACCINATION SITE WARMTH (arm is hard, red, warm and itching at injection site,), INJECTION SITE PRURITUS (arm is hard, red, warm and itching at injection site,) and INDURATION (arm is hard, red, warm and itching at injection site,). On 01-Apr-2021, PAIN IN EXTREMITY (arm is in pain) had resolved. At the time of the report, ERYTHEMA (arm is hard, red, warm and itching at injection site,), HEADACHE (headache), VACCINATION SITE WARMTH (arm is hard, red, warm and itching at injection site,), INJECTION SITE PRURITUS (arm is hard, red, warm and itching at injection site,) and INDURATION (arm is hard, red, warm and itching at injection site,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment products information was provided.
Skin rash, rash, erythema multiforme, urticarial pruritus and edema.
Information has been received from a licensed practical nurse concerning a 25 year old female with no drug reactions/allergies, and unknown date of last menstrual period due to irregular periods and a history of 2 live children (number of pregnancies was not reported) who on 25 Oct 2006 was vaccinated with first dose of HPV vaccine. There was no concomitant medication. The patient sought medical attention. Around 25 Nov 2006, (Thanksgiving time), the patient presented to the office. She had an ectopic pregnancy, went to the emergency room and was administered methotrexate to abort the child. She was monitored for several hours and released. The patient was not hospitalized. It was unk if the patient was pregnant when she was vaccinated with HPV Vaccine due to irregular periods, unknown LMP. At the time of reporting, the patient was recovering, her quantitative HCG was at 85, it should be at 2, but was going downward. The reporter felt that the event required intervention to prevent serious criteria (other important medical event) (OMIC). This report is part of the pregnancy registry. Additional information has been requested.
A couple minutes after getting the vaccine, I felt tingling in my toes for a few minutes and then it stopped and never felt that again. I started feeling fever and having chills around 9:30PM on the same day I got the shot. I woke up sweating, with a severe headache and I couldn't move my arm due to the pain. I took acetaminophen to reduce the fever and the pain.
This spontaneous report was received from a registered nurse and refers to a multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with an unspecified doses of COMVAX (doses, lot numbers, expiration dates, routes of administration were not reported), that had undergone multiple unspecified temperature excursions. The information regarding temperature, time frame and previous temperature excursions were unknown. The digital data logger was involved. There were no adverse effects reported. The product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA004383: US-009507513-1705USA004379: US-009507513-1705USA004380: US-009507513-1705USA004381: US-009507513-1705USA004382: US-009507513-1705USA004377: US-009507513-1705USA004376: US-009507513-1705USA004378:
This spontaneous case reported by a consumer, describes the occurrence of slight headache and a few chills in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient had a slight headache and a few chills. The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, slight headache and a few chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications taken by the patient: not provided. This case linked to MOD-2021-080404 (patient link).
pt recvd vax;weakness,paresthesia,"strange detached" feeling p/ 3rd dose in a post exposure series;very anxious about exposure;a cat came in from the woods & was rubbing against her vigorously & when she went to pick it up,cat bit her & ran
Pt received PNEUMOVAX and FLUZONE HD on 9/14/17. Both were given in left arm for medical reasons. Reports arm is swollen, red, sore, and hot to touch.
7 day p/vax pt exp wheezing & treated w/albuterol nebulizer. on 16mar99 pt oxygen saturation was 90%. addl info avail
I started having numbness on the right side of face from ear/unilateral numbness on the right side of her face, from her ear all the way down to chin; loss taste/lost ultra-sense of taste on the right side of her month and tongue; burning sensation/burning sensation on her tongue and mouth unilaterally; Trimengular" neuralgia; pain in her right ear; an outbreak of a cold sore; an outbreak of a cold sore; had a herpes zoster outbreak, on my lip; I had 2 teeth(rt side) extracted after the booster; I have had symptoms but they feel like they are swollen, even though they are not swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 25Oct2021 (Lot number: EW0185) at the age of 67 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose: , NDC: Unknown, Lot:  EN6198, Expiry date: Unknown, Date of vaccination: 24Feb2021), administration date: 24Feb2021, for COVID-19 Immunization; Bnt162b2 (Second Pfizer covid-19 vaccine: , NDC: Unknown, Lot:  EN6198, Expiry date: Unknown, Date of vaccination:  13Mar2021), administration date: 31Mar2021, for COVID-19 Immunization. The following information was reported: HERPES ZOSTER (non-serious) with onset 25Nov2021, outcome "unknown", described as "had a herpes zoster outbreak, on my lip"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "I started having numbness on the right side of face from ear/unilateral numbness on the right side of her face, from her ear all the way down to chin"; AGEUSIA (non-serious), outcome "unknown", described as "loss taste/lost ultra-sense of taste on the right side of her month and tongue"; BURNING SENSATION (non-serious), outcome "unknown", described as "burning sensation/burning sensation on her tongue and mouth unilaterally"; TRIGEMINAL NEURALGIA (non-serious), outcome "unknown", described as "Trimengular" neuralgia"; NASOPHARYNGITIS (non-serious), PAIN (non-serious) all with onset Dec2021, outcome "unknown" and all described as "an outbreak of a cold sore"; EAR PAIN (non-serious), outcome "unknown", described as "pain in her right ear"; TOOTH EXTRACTION (non-serious) with onset 05Nov2021, outcome "unknown", described as "I had 2 teeth(rt side) extracted after the booster"; SWELLING (non-serious) with onset 05Nov2021, outcome "unknown", described as "I have had symptoms but they feel like they are swollen, even though they are not swollen". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of trigeminal neuralgia. No follow-up attempts are possible. No further information is expected.
Vaccinated with ZOSTAVAX at approx 1pm 2/18. Patient went to Dr 2/21 AM with blisters at site of injection and redness about the size of the palm of your hand. It was hot to touch. Patient was placed on VALTREX 1 GM TID.
Extreme fatigue and nausea   6w6d pregnant at time of vaccine   2 previous healthy full term pregnancies
PT CAME TO PHARMACY ON 1-3-2022 TO INFORM US THAT AFTER HER PNEUMONIA 23 VACCINE, HER ARM WAS IN PAIN AND PARALYZED. SHE HAD PREDNISONE PRESCRIBED BY HER PRIMARY CARE DOCTOR. SHE SPOKE TO PHARMACIST THAT ADMINISTERED HER VACCINE
pt had convuls 1FEB95; MD was called to check pt temp APAP given; temp checked 1 hr p/APAP t102-103; 2nd convuls @ 18 1/2 mo 29APR95 pt was febrile;
soreness at injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Endometrial carcinoma. Concomitant products included LENVATINIB MESILATE (LENVIMA) from 22-Jul-2021 to an unknown date for Endometrial carcinoma, PEMBROLIZUMAB (KEYTRUDA) for an unknown indication.    On 16-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). At the time of the report, VACCINATION SITE PAIN (soreness at injection site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided. Treatment information was not provided.
extreme fatigue. I slept for two days following both vaccines, decreased energy. Sore arm which after the second dose remains a dull ache now at  two weeks and 3 days after the second dose. Still have severe fatigue. I want to sleep all day.
PT C/O TIGHTNESS OF THROAT SHORTLY AFTER VACCINE ADMIN. PT SELF-ADMINISTERED OWN UNKNOWN ASTHMA MEDICATION, BUT WAS NOT FEELING SATISFACTORY RELIEF. PT WAS ADMINISTERED 25MG BENADRYL IM. 15 MINUTES AFTER ONSET OF S/S PT WAS BEGINNING TO FEEL BETTER AND WAS DRIVEN HOME BY RELATIVE.
On December 20th I became extremely itchy with hives that followed. Hives for me have never been itchy after a mild allergic reaction. After some research I found this was dermatographia. I took Zyrtec and Pepcid. Within 30 minutes the itchiness and rash had disappeared. 3 days later it returned. I took Zyrtec. 3 days later it came back, so I took Zyrtec.. this process continues for 2 weeks. Today it came back so I took Zyrtec again. I?m not sure if I would have connected it to the booster if my coworkers and friends who received the shot at similar times weren?t going through the same thing. Symptoms and timing post booster have been identical.
My primary care doctor describes what I am experiencing as dermatographia. I started off having an itchy spot on the back of my neck, lightly rubbed the spot, and then my skin became immediately inflamed causing swelling and redness.  I continue to experience this all over my body, it is not localized to one area. This has never happened to me before, I am not allergic to anything that I am aware of, and have never had a reaction from a vaccine previously.
This spontaneous report as received from a physician refers to a 70 year old male patient. On an unknown date the patient was vaccinated with one single shot of ZOSTAVAX. One day after vaccination with ZOSTAVAX, the patient developed herpes zoster (shingles) in the eye. The patient saw the doctor for medical attention. The physician prescribed ZOVIRAX, NEURONTIN, and Vitamin B12 as treatment for the herpes in the eye. The patient's outcome was unknown. The causal relationship was not reported. Additional information has been requested.
The night after the 1st shot i was very tired and had bad allergies. Two nights after I received the vaccine I felt a hard lump above my collarbone which was never there before and it was tender to the touch the next morning it appeared that all of my left side lymph node under my collarbone and under my left armpit were swollen as well as the hard Pearl shaped sized bump above my collarbone .I went to the doctor on Friday to have them evaluate and get some blood work I actually also followed up with my doctor today because Los hard bump is still present and it's slightly painful
sore throat; sweating; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single), for Covid-19 immunization; Covid-19 vaccine (Dose 2, single), for Covid-19 immunization. The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "sweating".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 09-JUL-2015, the patient was vaccinated with an expired dose of M-M-R II (LOT # J007155, expiration date: 20-JUN-2015) dose and route were not reported. No symptoms reported. Additional information has been requested.
This solicited report has been received from a consumer, concerning her daughter, a female patient of unknown age who enrolled in a marketed research. No relevant medical history or concurrent conditions were reported. On an unknown date, the patient was vaccinated with GARDASIL (dose number, dose, route, lot# and expiration date were not reported). Since unknown dates (reported as "now"), the patient had issues with pain and her muscles. the reporter stated that the patient was an amazing dancer who "now: no longer could dance. the outcome of the events was not reported. Causality assessment was not reported. Additional information is not expected as the reporter did not wish further contact.
Patient was asymptomatic but went for a annual physical in April 22, 2021 and had an EKG which showed a Left Bundle Branch Block.  Echocardiagram was performed in May 2021 - Ejection Fraction 30 to 35% and Lexiscan was completed on 7/22/21 and failed the test - fixed inferior, inferosepatel and apical walls consistent with prior infarct.  There is myoglobal hypokenesis with moderate hypokinesis of the apex.  LV function is moderately to severely reduced, LVEF 29%.  L Cardiac Cath by Dr. on 8/17/21 - no blockages noted in verbal report. Started on Losarten sodium 7/21 and Carvedilol 8/21.
Case number PHEH2012US021503 is an initial spontaneous report received from a consumer on 23 Oct 2012. This report refers to a male patient. He was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly on an unknown date in Sep 2012. He reported that he experienced bouts of shortness of breath shortly after receiving FLUVIRIN. It was reported that by the beginning of October, his shortness of breath was waking him up in the middle of the night and he went outside to catch his breath. He felt like he could not get enough air and it was like a bag was over his head. The shortness of breath occurred at night and while he was awake. The outcome of the event was not reported. No further information was available.
Information has been received from a registered nurse referring to multiple patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were not reported. On 01-AUG-2016 the patients was vaccinated with improperly stored (at 10.4 degree centigrade for 6 hours and 17 minutes) GARDASIL (lot # K010215 with expiration date of 05-MAY-2017, lot # K014191 with expiration date of 10-MAY-2017, lot # K008931 with expiration date 04-MAR-2017, dose and route unknown). There was no temperature excursion previously. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Patient said had the Moderna vaccine at pharmacy yesterday 3/24/21 about 2:30. Technician administered the vaccine with supervising in the same room. Patient came in today around 1 pm stating he was sore and couldn't sleep last night and today he has limited movement in left arm. He can lift it up to almost horizontal position forward but difficulty moving it backwards. He took 2 of the 200 mg Ibuprofen as directed and still sore. Advised he can take 4 of the 200 mg Ibuprofen (800 mg) every 8 hours for a day and see if that relieves pain and motion. He can also put a cold compress to affected area for slight swelling. If not better in a day or so advised him to contact a doctor, because might need something stronger to treat reaction to vaccine.
Tested positive for Covid-19; Tested positive for Covid-19; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 27 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 07Oct2021 (Lot number: EW0217) at the age of 26 years as dose 3 (booster), single, intramuscular, administered in arm left, administration date 26Jan2021 (Lot number: EL3247) as dose 1, single and intramuscular, administered in arm left, administration date 16Feb2021 (Lot number: 3248) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported IMMUNISATION (medically significant) with onset 07Oct2021, outcome unknown; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 17Dec2021, outcome unknown. The event tested positive for covid-19 and tested positive for covid-19 was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures sars-cov-2 test (17Dec2021) unknown results, Nasal Swab; (17Dec2021) positive, Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Patient had no received other vaccine in four weeks. Patient had no covid prior vaccination. Patient had covid tested post vaccination. Patient had no known allergies. Patient had covid test result pending.  No follow-up attempts needed. No further information expected.
This is a spontaneous report from a contactable nurse via a Pfizer sales Representative. This nurse reported similar events for three patients. This is the third of three reports. An elderly female patient received PREVNAR 13, (lot R33240, exp. date Mar2018, NDC number: 0005197101) at single dose on 01Feb2017 for immunization. On unknown date the patient experienced symptoms of redness at injection site, itching to the site, and heat to the site 1-2 days post injection, local swelling. The outcome of the events was unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2017063634 same reporter/drug/event, different patient; US-PFIZER INC-2017063627 same reporter/drug, similar events/patient.
Extremely hot, red area appearing in site of vaccine. Very painful and swollen. Lasted 8 days. Felt movement under the skin. Arm very weak since. General physical weakness since day of vaccination. First dose.  Very painful and very hot. Cannot sleep well and am exhausted all the time.
paresthesia of the left arm and hand; heaviness of the left arm.; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 46-year-old female patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK9231, expiry date 30Apr2021) via an unspecified route of administration in the left arm on 08Jan2021 at 15:30 for COVID-19 immunization. Medical history included migraine (she occasionally had migraines and treated it with ibuprofen). The patient's concomitant medication included ibuprofen for migraine (the last dose of Ibuprofen was two or three days ago before 08Jan2021). The patient had received the first single dose of BNT162B2 on 18Dec2020 for COVID-19 immunization and experienced soreness in the left arm which lasted for a day and a half. No other vaccine received within 4 weeks.   The patient experienced paresthesia of the left arm and hand on 08Jan2021. She received the first dose of the vaccine on 18Dec2020 in her left arm and had some soreness in the left arm at that time, which was resolved on 20Dec2020 (event reported in AER 2021019477). On 08Jan2021, she received the second dose also in her left arm and within five minutes she had this strange paresthesia of the left arm and hand. She also described it as strange heaviness of the left arm. No limited range of motion of the left arm. She didn't know if it was serious. She didn't visit emergency room or physician office. After two hours (the time of reporting) she still had the same sensation. The event was not resolved.   The reporter considered the event paresthesia of the left arm and hand was related to the vaccine.
Information has been received from a female who in May 2008 originally had shingles of the left buttock. Since then, she has had nausea and headache. On 22-JUL-2008, the patient was vaccinated with ZOSTAVAX. It was reported that on 05-SEP-2008, the headache became persistent. She was seen by her primary car physician and treated for a possible sinus infection. The patient then noticed light-sensitivity. The ophthalmologist found a normal eye exam so he referred the patient to neurologist who prescribed her Topamax and Verapamil for the headache. On 24-OCT-2008 the patient developed shingles of the left buttock area and was prescribed Acyclovir. On 30-OCT-2008 the patient developed a widespread, itchy rash with soreness inside her mouth and under her eyelids. The patient had an appointment scheduled with neurologist on 04-NOV-2008. At the time of the report the patient had not recovered. Additional information has been requested.
pt recv vax 13MAY97 & MAY97 pt devel wheezing which was treated w/tapered doses of pred;28JUL97 lab eval revealed a neg titer;
pt recvd APAP @ 1230PM & 6PM had some fever; mom states pt was cranky & not walking on leg; pt's father holding when had a sz; eyes rolled back; taken to ER;